Grandfield & Dodd’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,671
| Closed | -$80K | – | 194 |
|
|
2022
Q3 | $80K | Sell |
1,671
-583
| -26% | -$27.9K | 0.01% | 185 |
|
|
2022
Q2 | $130K | Sell |
2,254
-676
| -23% | -$39K | 0.01% | 191 |
|
|
2022
Q1 | $240K | Buy |
2,930
+224
| +8% | +$18.3K | 0.02% | 186 |
|
|
2021
Q4 | $550K | Buy |
2,706
+711
| +36% | +$145K | 0.04% | 132 |
|
|
2021
Q3 | $540K | Buy |
1,995
+124
| +7% | +$33.6K | 0.04% | 130 |
|
|
2021
Q2 | $480K | Buy |
1,871
+57
| +3% | +$14.6K | 0.03% | 134 |
|
|
2021
Q1 | $540K | Buy |
1,814
+147
| +9% | +$43.8K | 0.04% | 129 |
|
|
2020
Q4 | $430K | Buy |
1,667
+138
| +9% | +$35.6K | 0.03% | 132 |
|
|
2020
Q3 | $380K | Buy |
1,529
+33
| +2% | +$8.2K | 0.03% | 138 |
|
|
2020
Q2 | $520K | Buy |
1,496
+244
| +19% | +$84.8K | 0.05% | 121 |
|
|
2020
Q1 | $335K | Buy |
1,252
+204
| +19% | +$54.6K | 0.04% | 135 |
|
|
2019
Q4 | $339K | Buy |
+1,048
| New | +$339K | 0.03% | 145 |
|